Provided by Tiger Fintech (Singapore) Pte. Ltd.

Zentalis Pharmaceuticals, LLC

1.45
+0.09006.62%
Volume:553.52K
Turnover:782.94K
Market Cap:104.13M
PE:-0.62
High:1.45
Open:1.39
Low:1.36
Close:1.36
Loading ...

Zentalis Pharmaceuticals Announces Multiple Data Presentations at Society of Gynecologic Oncology 2025 Annual Meeting on Women’s Cancer

THOMSON REUTERS
·
03 Mar

Zentalis Pharmaceuticals Announces Multiple Data Presentations at Society of Gynecologic Oncology 2025 Annual Meeting on Women’s Cancer

GlobeNewswire
·
03 Mar

Zentalis Pharmaceuticals Inc expected to post a loss of 71 cents a share - Earnings Preview

Reuters
·
28 Feb

Zentalis Pharmaceuticals Inc expected to post a loss of 71 cents a share - Earnings Preview

Reuters
·
21 Feb

Deep Track Capital Nominates Four Highly Qualified Candidates for Election to Dynavax Technologies’ Board of Directors at 2025 Annual Meeting

Business Wire
·
19 Feb

Zentalis Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
04 Feb

Zentalis Pharmaceuticals (ZNTL) Loses -46.3% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Zacks
·
03 Feb

Guggenheim Sticks to Their Buy Rating for Zentalis Pharmaceuticals (ZNTL)

TIPRANKS
·
30 Jan

BUZZ-Zentalis Pharma tumbles on cancer drug durability concerns

Reuters
·
30 Jan

Zentalis Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
30 Jan

Zentalis price target lowered to $10 from $20 at H.C. Wainwright

TIPRANKS
·
29 Jan

Zentalis Pharmaceuticals Shares Updated Clinical Data Demonstrating Meaningful Azenosertib Activity in Cyclin E1+, Platinum-Resistant Ovarian Cancer

THOMSON REUTERS
·
29 Jan

Zentalis Pharmaceuticals: Topline Data From Registration-Intent Denali Part 2 Anticipated by Year End 2026

THOMSON REUTERS
·
29 Jan

Zentalis Pharmaceuticals to Cut 40% of Workforce

MT Newswires Live
·
29 Jan

Zentalis Pharmaceuticals Inc - Workforce Reduction Expected to Be Completed in Q2 2025

THOMSON REUTERS
·
29 Jan

Zentalis Pharmaceuticals Inc - Planned Workforce Reduction of Approximately 40% of Employees

THOMSON REUTERS
·
29 Jan

Zentalis Pharmaceuticals Inc - Extended Cash Runway Into Late 2027

THOMSON REUTERS
·
29 Jan

Zentalis Pharmaceuticals Announces Strategic Restructuring to Support Late-Stage Azenosertib Development

THOMSON REUTERS
·
29 Jan

Zentalis Pharma Says FDA Grants Fast Track Status on Azenosertib Cancer Drug Candidate

MT Newswires Live
·
10 Jan

Zentalis Pharmaceuticals (ZNTL) Upgraded to Strong Buy: What Does It Mean for the Stock?

Zacks
·
10 Jan